Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer
- 13 July 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 127 (3), 601-610
- https://doi.org/10.1007/s10549-010-1015-8
Abstract
Male breast cancer (MBC) is a poorly characterized disease because of its rarity. Clinical management is based on results obtained from randomized trials conducted in women notwithstanding data in the literature suggesting relevant gender-associated differences in terms of biological and clinical behavior. However, a genome-wide characterization of MBC on a transcriptional level is lacking. In this study, gene expression profiles of 37 estrogen receptor positive (ER+) MBC specimens were compared to that of 53 ER+ Female Breast Cancer (FBC) samples similar for clinical and patho-biological features. Almost 1000 genes were found differentially expressed (FDR < 1%) between female and male patients and biological interpretation highlighted a gender-associated modulation of key biological processes ranging from energy metabolism to regulation of translation and matrix remodeling as well as immune system recruitment. Moreover, an analysis of genes correlated to steroid receptors and ERBB2 suggested a prominent role for the androgen receptor in MBC with a minor relevance for progesterone receptor and ERBB2, although, similarly to FBC, a genomic amplification could be observed. Our findings support the idea that breast cancer is a quite different disease in male and female patients and the underlying gender-related biological differences are likely to have clinical implications connected with different susceptibility to treatment.Keywords
This publication has 52 references indexed in Scilit:
- Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literatureBMC Cancer, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Gene-Expression Signatures in Breast CancerThe New England Journal of Medicine, 2009
- Molecular Mechanisms and Clinical Implications of Reversible ProteinS-GlutathionylationAntioxidants and Redox Signaling, 2008
- The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast CancerCancer Research, 2008
- Male breast cancer: is the scenario changingWorld Journal of Surgical Oncology, 2008
- Rho GTPases in cancer cell biologyFEBS Letters, 2008
- TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cellsBreast Cancer Research, 2008
- A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast CancerClinical Cancer Research, 2008
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001